Nephro Care India Ltd
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions[1]
- Market Cap ₹ 379 Cr.
- Current Price ₹ 230
- High / Low ₹ 379 / 171
- Stock P/E 129
- Book Value ₹ 32.1
- Dividend Yield 0.00 %
- ROCE 60.4 %
- ROE 49.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.5%
Cons
- Stock is trading at 7.16 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -23.6%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|
| 0.54 | 1.82 | 3.42 | 17.09 | 27.23 | 31.82 | |
| 0.52 | 1.67 | 3.28 | 13.66 | 20.76 | 26.06 | |
| Operating Profit | 0.02 | 0.15 | 0.14 | 3.43 | 6.47 | 5.76 |
| OPM % | 3.70% | 8.24% | 4.09% | 20.07% | 23.76% | 18.10% |
| 0.01 | 0.01 | -0.01 | 0.00 | 0.28 | 0.79 | |
| Interest | 0.04 | 0.03 | 0.02 | 0.07 | 0.09 | 0.09 |
| Depreciation | 0.00 | 0.01 | 0.11 | 0.78 | 0.53 | 0.98 |
| Profit before tax | -0.01 | 0.12 | 0.00 | 2.58 | 6.13 | 5.48 |
| Tax % | 0.00% | 25.00% | 7.75% | 28.06% | ||
| -0.01 | 0.09 | -0.01 | 2.37 | 4.41 | 2.95 | |
| EPS in Rs | -10.00 | 90.00 | -0.20 | 47.40 | 3.71 | 1.97 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 146% |
| TTM: | 59% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 263% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 60% |
| Last Year: | 49% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.50 | 0.50 | 11.90 | 16.49 |
| Reserves | 0.07 | 0.01 | 0.00 | 2.03 | 3.12 | 36.46 |
| 0.40 | 0.69 | 2.54 | 2.48 | 0.00 | 0.00 | |
| 0.30 | 0.42 | 1.60 | 3.25 | 5.94 | 14.21 | |
| Total Liabilities | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 67.16 |
| 0.45 | 0.06 | 1.39 | 3.01 | 4.74 | 5.70 | |
| CWIP | 0.00 | 0.45 | 1.90 | 0.00 | 0.86 | 17.78 |
| Investments | 0.24 | 0.00 | 0.00 | 2.00 | 6.51 | 25.03 |
| 0.09 | 0.62 | 1.35 | 3.25 | 8.85 | 18.65 | |
| Total Assets | 0.78 | 1.13 | 4.64 | 8.26 | 20.96 | 67.16 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 0.23 | 0.62 | 4.12 | 0.91 | ||
| -0.06 | -2.81 | -2.33 | -7.54 | ||
| 0.28 | 2.32 | -0.08 | 5.60 | ||
| Net Cash Flow | 0.44 | 0.13 | 1.71 | -1.03 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 20.28 | 0.85 | 2.01 |
| Inventory Days | 8.83 | 41.93 | 35.25 | 14.07 | |
| Days Payable | 94.19 | 113.45 | 69.03 | 75.17 | |
| Cash Conversion Cycle | 0.00 | -85.36 | -51.24 | -32.93 | -59.09 |
| Working Capital Days | -168.98 | -74.20 | -117.40 | -55.96 | -36.86 |
| ROCE % | 25.21% | 1.60% | 65.84% | 60.41% |
Documents
Announcements
-
Financial Result Updates
8 November 2024 - Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Outcome of Board Meeting
8 November 2024 - Nephro Care India Limited has informed regarding Board meeting held on November 08, 2024.
-
Board Meeting Intimation
30 October 2024 - NEPHRO CARE INDIA LIMITED has informed about Board Meeting to be held on 08-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the …
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
14 October 2024 - Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2024-25
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
7 October 2024 - Nephro Care India Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Services Offered[1]
In-house Dialysis Unit
Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology
NABL accredited inhouse Pathology
Inhouse Pharmacy
Advance diagnostic facilities
Renal Nutrition department
Home Care
Mukti (Lifestyle Support Program)
Home Dialysis